CompanyDeals

Full-Life Technologies Secures USD 63.3 Million in Financing to Boost Radiotherapeutics Pipeline and Manufacturing

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Secures NMPA Approval for Abiraterone in Prostate Cancer Treatment

CompanyDrug

ImmunoTech Biopharm Commences Patient Enrollment in Phase II Study for CAR-T-19 Injection

Company

Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer to Lead Pipeline Strategy

CompanyDeals

GenScipt Subsidiary Legend Biotech Finalizes Licensing Deal with Novartis for DLL3 CAR-T Therapies

CompanyDrug

Sino Biopharmaceutical Ltd Secures Exclusive Rights for Generic Everolimus in China

CompanyDeals

Kexing Pharmaceutical Enters Global Licensing Agreement with Xiling Lab for Eribulin Generic

CompanyDeals

Bio-Thera Solutions Grants Macter International Exclusive Rights to Avzivi in Pakistan and Afghanistan

CompanyDeals

Boehringer Ingelheim Partners with Suzhou Ribo Life Science to Develop siRNA Therapies for NASH/MASH

CompanyDrug

Sciwind Biosciences’ Ecnolgutide Shows Promising Phase III Results in Type 2 Diabetes Treatment

CompanyDeals

JW Therapeutics and 2seventy Bio Ink Exclusive Deal for CAR-T Cell Therapy in Greater China

CompanyDrug

InventisBio’s KRAS G12C Inhibitor Garsorasib NDA Accepted for Review by China’s NMPA